| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
7 companies
Thompson Peter A. is a Director, 10% Owner at PMV Pharmaceuticals, Inc. with holdings across 7 companies. Recent SEC Form 4 filings include 13 buys and 5 sells.
Estimated insider holdings value: $128.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2021 | JANX Janux Therapeutics, Inc. | Director | Buy | 705,853 | $17.00 | $11,999,501.00 | +30.2% | +52.6% | -37.6% | |
| Mar 30, 2021 | EWTX Edgewise Therapeutics, Inc. | Director, 10% Owner | Buy | 359,375 | $16.00 | $5,750,000.00 | +2.7% | -23.8% | -70.3% | |
| Feb 17, 2021 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,285,714 | $3.50 | $4,499,999.00 | +19.0% | - | - | |
| Dec 8, 2020 | SPRY Ars Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,190,477 | $21.00 | $25,000,017.00 | +442.0% | - | - | |
| Sep 25, 2020 | PMVP Pmv Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 950,000 | $18.00 | $17,100,000.00 | New | - | - | |
| Aug 6, 2019 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 142,656 | $3.51 | $500,722.56 | +2.2% | - | - | |
| Jul 1, 2019 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 657,344 | $3.72 | $2,444,065.11 | +3.5% | - | - | |
| Jun 6, 2018 | Director | Sell | 18,700 | $13.56 | $253,631.00 | -0.2% | - | - | ||
| Jun 1, 2018 | Director | Sell | 171,000 | $13.51 | $2,310,420.00 | -1.7% | - | - | ||
| May 14, 2018 | Director | Sell | 10,300 | $13.50 | $139,050.00 | -0.2% | - | - |